The Bacterial Sec Pathway of Protein Export: Screening and Follow-Up

Area of Science:

• Microbiology
• Molecular Biology
• Drug Discovery

Background:

• The SecYEG channel is crucial for bacterial protein export.
• The Sec pathway is a potential target for novel antibiotics.
• Previous drug discovery efforts have focused heavily on the SecA ATPase component.

Purpose of the Study:

• To conduct a pathway-based screen for inhibitors of the SecYEG protein translocation channel.
• To identify novel compounds that impair bacterial protein export.
• To overcome limitations of previous research by focusing on the entire Sec pathway.

Main Methods:

• Utilized a beta-galactosidase (β-gal) reporter assay in Escherichia coli to detect impaired protein translocation.
• Performed a screen to identify compounds that trap β-gal in the cytoplasm.
• Conducted counterscreens to differentiate between inhibited export and β-gal overexpression.
• Evaluated the growth inhibition and mechanism of action of hit compounds.

Main Results:

• Identified several hit compounds that impaired β-gal export.
• The most characterized hit compound showed weak E. coli growth inhibition (EC50 ≥ 400 µM).
• The precise mechanism of growth inhibition for the lead compound could not be definitively linked to Sec pathway disruption.

Conclusions:

• Pathway-based screening can identify compounds affecting protein export.
• Finding potent and druglike inhibitors for the Sec pathway presents significant challenges.
• Further research is needed to overcome hurdles in targeting the Sec pathway for antibiotic development.